Location History:
- High Wycombe, GB (1998 - 2003)
- Buckinghamshire, GB (2005)
- Amersham, GB (2006)
Company Filing History:
2 out of 84 
2 out of 189 
1 out of 16 Years Active: 1998-2006
Title: Alan Michael Forster: Innovator in Radiopharmaceuticals
Introduction
Alan Michael Forster is a notable inventor based in High Wycombe, GB. He has made significant contributions to the field of radiopharmaceuticals, holding a total of five patents. His work focuses on enhancing the stability and effectiveness of radiopharmaceutical compositions.
Latest Patents
Among his latest patents is the invention of stabilized radiopharmaceutical compositions. This invention relates to compositions that include both a radioprotectant and one or more antimicrobial preservatives, thereby extending their lifetime of use. The radioprotectants used in these compositions include ascorbic acid, para-aminobenzoic acid, gentisic acid, or a salt thereof with a biocompatible cation. The antimicrobial preservatives are selected from the paraben series. This invention is particularly beneficial for cationic, lipophilic Tc heart imaging agents such as Myoview™. Another significant patent involves labelled factor XIIIa substrates. This complex consists of a radiometal or paramagnetic metal ion with a metal chelating agent, which can function as a substrate for the fibrin-stabilizing Factor XIIIa. This complex is useful for diagnosing or treating conditions such as thrombosis, embolism, atherosclerosis, inflammation, or cancer.
Career Highlights
Throughout his career, Alan has worked with prominent companies in the healthcare sector, including Amersham International Plc and GE Healthcare Limited. His experience in these organizations has contributed to his expertise in the development of innovative radiopharmaceuticals.
Collaborations
Alan has collaborated with notable professionals in his field, including Anthony Eamon Storey and Peter Knox. These collaborations have likely enriched his research and development efforts.
Conclusion
Alan Michael Forster is a distinguished inventor whose work in radiopharmaceuticals has the potential to significantly impact medical diagnostics and treatment. His innovative patents and collaborations reflect his commitment to advancing healthcare technology.